<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:WDDD="http://worlds.com/20250331"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="wddd-20250331.xsd" xlink:type="simple"/>
    <context id="From2025-01-01to2025-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-05-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
        </entity>
        <period>
            <instant>2026-05-08</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_AntidilutiveSecuritiesNameDomain">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:AntidilutiveSecuritiesNameDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_AntidilutiveSecuritiesNameDomain">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:AntidilutiveSecuritiesNameDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2001-04-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
        </entity>
        <period>
            <instant>2001-04-01</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_Outstanding1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">WDDD:Outstanding1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_Outstanding2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">WDDD:Outstanding2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_Outstanding3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">WDDD:Outstanding3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_Exercisable1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">WDDD:Exercisable1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_Exercisable2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">WDDD:Exercisable2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_Exercisable3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">WDDD:Exercisable3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
        </entity>
        <period>
            <instant>2019-08-28</instant>
        </period>
    </context>
    <context id="AsOf2019-08-28_custom_Additionalbonus1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">WDDD:Additionalbonus1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-28</instant>
        </period>
    </context>
    <context id="AsOf2019-08-28_custom_Additionalbonus2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">WDDD:Additionalbonus2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-28</instant>
        </period>
    </context>
    <context id="From2019-08-282019-08-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
        </entity>
        <period>
            <startDate>2019-08-28</startDate>
            <endDate>2019-08-29</endDate>
        </period>
    </context>
    <context id="AsOf2018-08-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
        </entity>
        <period>
            <instant>2018-08-28</instant>
        </period>
    </context>
    <context id="AsOf2020-08-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
        </entity>
        <period>
            <instant>2020-08-28</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2011-01-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000001961</identifier>
        </entity>
        <period>
            <instant>2011-01-01</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Years">
        <measure>utr:Y</measure>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Interger">
        <measure>WDDD:Interger</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2025-01-01to2025-03-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="From2025-01-01to2025-03-31" id="Fact000004">2025</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2025-01-01to2025-03-31" id="Fact000005">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate contextRef="From2025-01-01to2025-03-31" id="Fact000006">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityCentralIndexKey contextRef="From2025-01-01to2025-03-31" id="Fact000007">0000001961</dei:EntityCentralIndexKey>
    <us-gaap:LoansPayableCurrent
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0072"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2025-01-01to2025-03-31"
      id="xdx2ixbrl0112"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2024-01-012024-03-31"
      id="xdx2ixbrl0113"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2025-01-01to2025-03-31"
      id="xdx2ixbrl0115"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2024-01-012024-03-31"
      id="xdx2ixbrl0116"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CostOfRevenue
      contextRef="From2025-01-01to2025-03-31"
      id="xdx2ixbrl0121"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CostOfRevenue
      contextRef="From2024-01-012024-03-31"
      id="xdx2ixbrl0122"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GrossProfit
      contextRef="From2025-01-01to2025-03-31"
      id="xdx2ixbrl0124"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GrossProfit
      contextRef="From2024-01-012024-03-31"
      id="xdx2ixbrl0125"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0156"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0157"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31_us-gaap_WarrantMember"
      id="xdx2ixbrl0158"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0178"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-012025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0179"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-012025-03-31_us-gaap_WarrantMember"
      id="xdx2ixbrl0180"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInNotesPayableRelatedPartiesCurrent
      contextRef="From2024-01-012024-03-31"
      id="xdx2ixbrl0217"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2024-01-012024-03-31"
      id="xdx2ixbrl0220"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaid
      contextRef="From2025-01-01to2025-03-31"
      id="xdx2ixbrl0237"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaid
      contextRef="From2024-01-012024-03-31"
      id="xdx2ixbrl0238"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2025-01-01to2025-03-31"
      id="xdx2ixbrl0240"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2024-01-012024-03-31"
      id="xdx2ixbrl0241"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2025-03-31_srt_MinimumMember"
      id="xdx2ixbrl0287">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2025-03-31_srt_MaximumMember"
      id="xdx2ixbrl0289">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <dei:DocumentType contextRef="From2025-01-01to2025-03-31" id="Fact000015">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="From2025-01-01to2025-03-31" id="Fact000016">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="From2025-01-01to2025-03-31" id="Fact000017">2025-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="From2025-01-01to2025-03-31" id="Fact000018">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2025-01-01to2025-03-31" id="Fact000019">000-24115</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2025-01-01to2025-03-31" id="Fact000020">GEMAXEL INC. (formerly known as Worlds Inc.)</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2025-01-01to2025-03-31" id="Fact000021">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2025-01-01to2025-03-31" id="Fact000022">22-1848316</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2025-01-01to2025-03-31" id="Fact000023">4775 Collins Ave</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2025-01-01to2025-03-31" id="Fact000024">Apt 2508</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2025-01-01to2025-03-31" id="Fact000025">Miami Beach</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2025-01-01to2025-03-31" id="Fact000026">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2025-01-01to2025-03-31" id="Fact000027">33140</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2025-01-01to2025-03-31" id="Fact000028">917</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2025-01-01to2025-03-31" id="Fact000029">270-1187</dei:LocalPhoneNumber>
    <dei:EntityCurrentReportingStatus contextRef="From2025-01-01to2025-03-31" id="Fact000030">No</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2025-01-01to2025-03-31" id="Fact000031">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2025-01-01to2025-03-31" id="Fact000032">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2025-01-01to2025-03-31" id="Fact000033">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2025-01-01to2025-03-31" id="Fact000034">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="From2025-01-01to2025-03-31" id="Fact000035">true</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2026-05-08"
      decimals="INF"
      id="Fact000036"
      unitRef="Shares">57112506</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000044"
      unitRef="USD">3396</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000045"
      unitRef="USD">6380</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000047"
      unitRef="USD">6563</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000048"
      unitRef="USD">8750</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000050"
      unitRef="USD">9959</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000051"
      unitRef="USD">15130</us-gaap:AssetsCurrent>
    <us-gaap:Assets
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000053"
      unitRef="USD">9959</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000054"
      unitRef="USD">15130</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000062"
      unitRef="USD">833228</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000063"
      unitRef="USD">809928</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000065"
      unitRef="USD">384765</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000066"
      unitRef="USD">316765</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000068"
      unitRef="USD">1784333</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000069"
      unitRef="USD">1768703</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LoansPayableCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000071"
      unitRef="USD">4500</us-gaap:LoansPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000074"
      unitRef="USD">773279</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000075"
      unitRef="USD">773279</us-gaap:NotesPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000077"
      unitRef="USD">3780105</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000078"
      unitRef="USD">3668675</us-gaap:LiabilitiesCurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000080"
      unitRef="USD">3780105</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000081"
      unitRef="USD">3668675</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="Fact000085"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000086"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="Fact000087"
      unitRef="Shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000088"
      unitRef="Shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="Fact000089"
      unitRef="Shares">57112506</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000090"
      unitRef="Shares">57112506</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="Fact000091"
      unitRef="Shares">57112506</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000092"
      unitRef="Shares">57112506</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000083"
      unitRef="USD">57113</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000084"
      unitRef="USD">57113</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000094"
      unitRef="USD">42335725</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000095"
      unitRef="USD">42335725</us-gaap:AdditionalPaidInCapital>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000097"
      unitRef="USD">1206913</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000098"
      unitRef="USD">1206913</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000100"
      unitRef="USD">-47369897</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000101"
      unitRef="USD">-47253296</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000103"
      unitRef="USD">-3770146</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000104"
      unitRef="USD">-3653545</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000106"
      unitRef="USD">9959</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000107"
      unitRef="USD">15130</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="Fact000127"
      unitRef="USD">37365</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2024-01-012024-03-31"
      decimals="0"
      id="Fact000128"
      unitRef="USD">26765</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SalariesWagesAndOfficersCompensation
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="Fact000130"
      unitRef="USD">60498</us-gaap:SalariesWagesAndOfficersCompensation>
    <us-gaap:SalariesWagesAndOfficersCompensation
      contextRef="From2024-01-012024-03-31"
      decimals="0"
      id="Fact000131"
      unitRef="USD">60359</us-gaap:SalariesWagesAndOfficersCompensation>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="Fact000133"
      unitRef="USD">-97863</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-01-012024-03-31"
      decimals="0"
      id="Fact000134"
      unitRef="USD">-87124</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="Fact000136"
      unitRef="USD">18738</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2024-01-012024-03-31"
      decimals="0"
      id="Fact000137"
      unitRef="USD">18738</us-gaap:InterestExpense>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="Fact000139"
      unitRef="USD">-116601</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31"
      decimals="0"
      id="Fact000140"
      unitRef="USD">-105862</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-01-01to2025-03-31"
      decimals="INF"
      id="Fact000142"
      unitRef="USDPShares">-0.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-01-012024-03-31"
      decimals="INF"
      id="Fact000143"
      unitRef="USDPShares">-0.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-01-01to2025-03-31"
      decimals="INF"
      id="Fact000145"
      unitRef="Shares">57112506</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-01-012024-03-31"
      decimals="INF"
      id="Fact000146"
      unitRef="Shares">57112506</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000154"
      unitRef="Shares">57112506</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000148"
      unitRef="USD">57113</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000149"
      unitRef="USD">42335725</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_WarrantMember"
      decimals="0"
      id="Fact000150"
      unitRef="USD">1206913</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000151"
      unitRef="USD">-46741914</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000152"
      unitRef="USD">-3142163</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000159"
      unitRef="USD">-105862</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31"
      decimals="0"
      id="Fact000160"
      unitRef="USD">-105862</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000168"
      unitRef="Shares">57112506</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000162"
      unitRef="USD">57113</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000163"
      unitRef="USD">42335725</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_WarrantMember"
      decimals="0"
      id="Fact000164"
      unitRef="USD">1206913</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000165"
      unitRef="USD">-46847776</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="Fact000166"
      unitRef="USD">-3248025</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000176"
      unitRef="Shares">57112506</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000170"
      unitRef="USD">57113</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000171"
      unitRef="USD">42335725</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_WarrantMember"
      decimals="0"
      id="Fact000172"
      unitRef="USD">1206913</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000173"
      unitRef="USD">-47253294</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000174"
      unitRef="USD">-3653545</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-012025-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000181"
      unitRef="USD">-116601</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="Fact000182"
      unitRef="USD">-116601</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000190"
      unitRef="Shares">57112506</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000184"
      unitRef="USD">57113</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000185"
      unitRef="USD">42335725</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31_us-gaap_WarrantMember"
      decimals="0"
      id="Fact000186"
      unitRef="USD">1206913</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000187"
      unitRef="USD">-47369897</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000188"
      unitRef="USD">-3770146</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="Fact000195"
      unitRef="USD">-116601</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31"
      decimals="0"
      id="Fact000196"
      unitRef="USD">-105862</us-gaap:NetIncomeLoss>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="Fact000201"
      unitRef="USD">-2187</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2024-01-012024-03-31"
      decimals="0"
      id="Fact000202"
      unitRef="USD">6000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="Fact000204"
      unitRef="USD">68000</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities
      contextRef="From2024-01-012024-03-31"
      decimals="0"
      id="Fact000205"
      unitRef="USD">10000</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="Fact000207"
      unitRef="USD">38930</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2024-01-012024-03-31"
      decimals="0"
      id="Fact000208"
      unitRef="USD">12251</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="Fact000210"
      unitRef="USD">-7484</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2024-01-012024-03-31"
      decimals="0"
      id="Fact000211"
      unitRef="USD">-89611</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:IncreaseDecreaseInNotesPayableRelatedPartiesCurrent
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="Fact000216"
      unitRef="USD">4500</us-gaap:IncreaseDecreaseInNotesPayableRelatedPartiesCurrent>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="Fact000219"
      unitRef="USD">4500</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="Fact000222"
      unitRef="USD">-2984</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2024-01-012024-03-31"
      decimals="0"
      id="Fact000223"
      unitRef="USD">-89611</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000225"
      unitRef="USD">6380</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000226"
      unitRef="USD">244856</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000228"
      unitRef="USD">3396</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="Fact000229"
      unitRef="USD">155245</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2025-01-01to2025-03-31" id="Fact000247">&lt;p id="xdx_80F_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zoSmFP8EVs9d" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 1 &#x2013; &lt;span id="xdx_820_zhypXibqRZ47"&gt;GOING CONCERN&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As reflected in the accompanying financial statements, the Company has a working
capital deficiency of $&lt;span id="xdx_90A_eus-gaap--StockholdersEquityPeriodIncreaseDecrease_c20250101__20250331_zFAWxHRTac99" title="Working capital deficiency"&gt;3,770,146&lt;/span&gt; and a stockholder&#x2019;s deficiency of $&lt;span id="xdx_902_eus-gaap--StockholdersEquityPeriodIncreaseDecrease_c20250101__20250331_z3pVA6QXzvE4" title="Stcokholders deficiency"&gt;3,770,146&lt;/span&gt; and used $&lt;span id="xdx_90C_eus-gaap--IncreaseDecreaseInOperatingCapital_c20250101__20250331_zz22xGcWEiyf" title="Cash in operations"&gt;7,484&lt;/span&gt; of cash in operations for the three
months ended March 31, 2025. This raises substantial doubt about its ability to continue as a going concern. The ability of the Company
to continue as a going concern is dependent on the Company&#x2019;s ability to raise additional capital and implement its business plan.
The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Management believes that the actions presently being taken to obtain additional
funding and implement its strategic plans provide the opportunity for the Company to continue as a going concern, although no assurance
can be given that the Company will be successful.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="Fact000249"
      unitRef="USD">3770146</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="Fact000251"
      unitRef="USD">3770146</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <us-gaap:IncreaseDecreaseInOperatingCapital
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="Fact000253"
      unitRef="USD">7484</us-gaap:IncreaseDecreaseInOperatingCapital>
    <us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2025-01-01to2025-03-31" id="Fact000255">&lt;p id="xdx_80F_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_z11UbmrHVpnl" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 2 &#x2013; &lt;span id="xdx_822_zkg3pD35W2l5"&gt;DESCRIPTION OF BUSINESS AND SUMMARY OF ACCOUNTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zyvxh8hzvFR" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Description of Business&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On March 26, 2026 the Company changed its name from Worlds Inc. to Gemaxel Inc.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On May 16, 2011, the Company transferred, through a spin-off to its then wholly
owned subsidiary, Worlds Online Inc. (currently called MariMed Inc.), the majority of its operations and related operational assets.
The Company retained its patent portfolio and its legacy celebrity worlds and its collection of non-fungible tokens.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_znwWO7fImrze" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The accompanying financial statements have been prepared in conformity with
accounting principles generally accepted in the United States of America ("US GAAP"). The Company has incurred significant losses since
its inception and has had minimal revenues from operations. The Company will require substantial additional funds for its expansion of
its legacy celebrity worlds and its collection of non-fungible tokens. There can be no assurance that the Company will be able to obtain
the substantial additional capital resources to pursue its business plan or that any assumptions relating to its business plan will prove
to be accurate. The Company has not been able to generate sufficient revenue or obtain sufficient financing which has had a material
adverse effect on the Company, including requiring the Company to reduce operations. As the Company has focused its attention historically
on increasing its patent portfolio and enforcing it, and more recently on its expansion of its legacy celebrity worlds and its collection
of non-fungible tokens, the Company has been operating at a reduced capacity, with only one employee and using consultants to perform
any additional work that may be required.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--UseOfEstimates_zpOmKIvdbOxj" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The preparation of financial statements in conformity with US GAAP requires
management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent
assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting
period. Actual results could differ from these estimates.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span style="font-size: 4pt"&gt;&#160;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z9tmwyUNZeLj" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Cash and Cash Equivalents&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash and cash equivalents include highly liquid money market instruments, which
have original maturities of three months or less at the time of purchase.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--RevenueRecognitionPolicyTextBlock_zNCMfFx77Rbd" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Revenue Recognition&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Effective January 1, 2018, the Company adopted ASC 606. There was no impact
in adopting ASC 606 as the Company has no revenue at this time. In the second quarter of 2011, the Company spun off its online businesses
to MariMed Inc. The Company&#x2019;s sources of revenue after the spinoff was expected to be from sublicenses of the patented technology
by Worlds Online and any revenue that may be generated from enforcing its patents. Commencing in the first half of 2023, the Company
expects that its revenues will come from its sales of it&#x2019;s intellectual properties. The Company recognizes revenue by applying
the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine
the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when
each performance obligation is satisfied.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--AdvertisingCostsPolicyTextBlock_zEMR8ua09pI4" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Advertising Expenses&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Advertising costs are expensed as incurred. There were &lt;span id="xdx_90E_eus-gaap--AdvertisingExpense_do_c20250101__20250331_zGg7C0T1jUL4" title="Advertising cost"&gt;&lt;span id="xdx_905_eus-gaap--AdvertisingExpense_do_c20240101__20240331_z3usRslWmln8" title="Advertising cost"&gt;no&lt;/span&gt;&lt;/span&gt; advertising costs
in the three months ended March 31, 2025 and 2024.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--ResearchAndDevelopmentExpensePolicy_zSBwhDjeLiff" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Research and Development Costs&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Research and development costs are charged to operations as incurred.&#160;There
were &lt;span id="xdx_907_eus-gaap--ResearchAndDevelopmentExpense_do_c20250101__20250331_zATOAWj7oosh" title="Research and development costs"&gt;&lt;span id="xdx_90E_eus-gaap--ResearchAndDevelopmentExpense_do_c20240101__20240331_zJbEHnFORAe9" title="Research and development costs"&gt;no&lt;/span&gt;&lt;/span&gt; research and development costs in the three months ended March 31, 2025 and 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--ReceivablesAndPortionsOfSecuritizationsThatCanBePrepaidAtPotentialLossPolicyPolicyTextBlock_zDnbm7a0y6na" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Prepaid Expenses&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Prepaid expenses is an annual fee paid to the OTC which is being amortized over
the life of the subscription. The balance at March 31, 2025 is $&lt;span id="xdx_90F_eus-gaap--PrepaidExpenseCurrent_iI_c20250331_zIGbcor3ZtDl" title="Prepaid expenses"&gt;6,563&lt;/span&gt;. The balance at December 31, 2024 is $&lt;span id="xdx_902_eus-gaap--PrepaidExpenseCurrent_iI_c20241231_z39PKCcKyYbb" title="Prepaid expenses"&gt;8,750&lt;/span&gt;.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z51XNCzD3qga" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Property and Equipment&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Property and equipment are stated at cost. Depreciation is provided on a straight
line basis over the estimated useful lives of the assets ranging from &lt;span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20250331__srt--RangeAxis__srt--MinimumMember_zCOBdbbhNJG3" title="Assets estimated useful lives::XDX::P3Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0287"&gt;three&lt;/span&gt;&lt;/span&gt; to &lt;span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20250331__srt--RangeAxis__srt--MaximumMember_zW6VPUZ0lCVd" title="Assets estimated useful lives::XDX::P5Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0289"&gt;five&lt;/span&gt;&lt;/span&gt; years. When assets are retired or disposed of, the
cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income. Maintenance
and repairs are charged to expense in the period incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zZGUvM4e1FXk" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Impairment of Long-Lived Assets&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company evaluates the recoverability of its fixed assets and other assets
in accordance with section 360-10-15 of the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification
(&#x201c;ASC&#x201d;) for disclosures about Impairment or Disposal of Long-Lived Assets. Disclosure requires recognition of impairment
of long-lived assets in the event the net book value of such assets exceeds its expected cash flows. If so, it is considered to be impaired
and is written down to fair value, which is determined based on either discounted future cash flows or appraised values. The Company
adopted the statement on inception. No impairments of these types of assets were recognized during the first quarter of 2025 and 2024.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zhKSXTyVwQfb" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 4pt"&gt;&#160;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Stock-Based
Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company accounts for stock-based compensation using the fair value method
following the guidance set forth in section 718-10 of the FASB ASC for disclosure about Stock-Based Compensation. This section requires
a public entity to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date
fair value of the award (with limited exceptions). That cost will be recognized over the period during which an employee is required
to provide services in exchange for the award (usually the vesting period). No compensation cost is recognized for equity instruments
for which employees do not render the requisite service.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--IncomeTaxPolicyTextBlock_zHIi1QhXCaG4" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Income Taxes&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company accounts for income taxes under Section 740-10-30 of the FASB ASC.
Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax basis of assets
and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.
Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets
will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in
the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities
of a change in tax rates is recognized in the consolidated statements of operations in the period that includes the enactment date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;ASC 740 prescribes a comprehensive model for how companies should recognize,
measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under
ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be
sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount
of tax benefit that has a greater than &lt;span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxSettlements_dp_c20250101__20250331_zOFfIVKxjVDa" title="Measured tax benefits"&gt;50&lt;/span&gt;% likelihood of being realized upon ultimate settlement with the tax authority assuming full
knowledge of the position and relevant facts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--ShortTermDebtTextBlock_z7CxHKZfsdji" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes Payable&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has $&lt;span id="xdx_909_eus-gaap--NotesPayableCurrent_iI_c20250331_zbYFujCBvTZh" title="Short terms notes"&gt;&lt;span id="xdx_90D_eus-gaap--NotesPayableCurrent_iI_c20241231_zzUVpTuevNc7" title="Short terms notes"&gt;773,279&lt;/span&gt;&lt;/span&gt; in short term notes outstanding at March 31, 2025 and
December 31, 2024. These are old notes payable for which the statute of limitations has passed and therefore the Company does not expect
it will ever have to repay those notes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--LoanCommitmentsPolicy_zPhjO4aEoaBg" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Loan
Payable Related Party&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company received a loan during the quarter from its CEO to pay operating
expenses. The balance at March 31, 2025 is $&lt;span id="xdx_906_eus-gaap--LoansPayableCurrent_iI_c20250331_z0qhm4Xq3hGl" title="CEO loan"&gt;4,500&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_zIcTLO5xmcQf" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Loss Per Share&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net loss per common share is computed pursuant to section 260-10-45 of the FASB
ASC. Basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during
the period. As of March 31, 2025, there were &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20250331_zE3nM751mIuh" title="Options"&gt;1,600,000&lt;/span&gt; options and &lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_do_c20240331_zIyqudo5bffg" title="Outstanding warrants"&gt;no&lt;/span&gt; warrants outstanding and as of March 31, 2024, there were &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240331_zQe9bz4jdy0f" title="Options"&gt;16,600,000&lt;/span&gt;
options and &lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_do_c20250331__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--AntidilutiveSecuritiesNameDomain_ztatvmh4pxKh" title=" Warrants outstanding"&gt;&lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_do_c20240331__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--AntidilutiveSecuritiesNameDomain_zzmXGFMkzXQf" title=" Warrants outstanding"&gt;no&lt;/span&gt;&lt;/span&gt; warrants outstanding whose effect is anti-dilutive and not included in diluted net loss per share for March 31, 2025 or
for March 31, 2024. The options and warrants may dilute future earnings per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zbk0tvaLiKNa" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Commitments and Contingencies&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company follows subtopic 450-20 of the FASB ASC to report accounting for
contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company
but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities,
and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are
pending against the Company or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any
legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 4pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;If the assessment of a contingency indicates that it is probable that a material
loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company&#x2019;s
financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible,
or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses,
if determinable and material, would be disclosed.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loss contingencies considered remote are generally not disclosed unless they
involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at
this time, that these matters will have a material adverse effect on the Company&#x2019;s financial position, results of operations or
cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company&#x2019;s business, financial
position, and results of operations or cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;During 2000 the Company was involved in a lawsuit relating to unpaid consulting
services. In April, 2001 a judgment against the Company was rendered for approximately $&lt;span id="xdx_90B_eus-gaap--LitigationReserveNoncurrent_iI_c20010401_zIONT3hvGtfc" title="Judgment amount"&gt;205,000&lt;/span&gt;. As of March 31, 2025, and December 31,
2024 the Company recorded a reserve of $&lt;span id="xdx_906_eus-gaap--LitigationReserve_iI_c20250331_z7uyhYqYw329" title="Reserve for lawsuit"&gt;&lt;span id="xdx_904_eus-gaap--LitigationReserve_iI_c20241231_zyAQHdiDmsNe" title="Reserve for lawsuit"&gt;205,000&lt;/span&gt;&lt;/span&gt; for this lawsuit, which is included in accrued expenses in the accompanying balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--UnusualRisksAndUncertaintiesTextBlock_z8iMXKoJq3Gh" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Risk and Uncertainties&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company is subject to risks common to companies in the technology industries,
including, but not limited to, litigation, development of new technological innovations and dependence on key personnel.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--OffBalanceSheetCreditExposurePolicyPolicyTextBlock_zj19VIoymAQ1" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Off Balance Sheet Arrangements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company does not have any off-balance sheet arrangements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--IncomeTaxUncertaintiesPolicy_zQAQSOFCVGMa" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Uncertain Tax Positions&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company did not take any uncertain tax positions and had no adjustments
to unrecognized income tax liabilities or benefits pursuant to the provisions of Section 740-10-25 for the year ended December 31, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z9JkpjgAZ875" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Fair Value of Financial Instruments&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company measures assets and liabilities at fair value based on an expected
exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on
the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such,
fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance
on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby
inputs, used in valuation techniques, are assigned a hierarchical level.&lt;span style="font-size: 4pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;



&lt;p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 4pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The following are the hierarchical levels of inputs to measure fair value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 11pt"&gt;
  &lt;tr&gt;
    &lt;td style="width: 3%; vertical-align: top"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2022;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="width: 97%; vertical-align: top"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level 1 - Observable inputs that reflect quoted market prices in active markets
for identical assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 11pt"&gt;
  &lt;tr&gt;
    &lt;td style="width: 3%; vertical-align: top"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2022;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="width: 97%; vertical-align: top"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level 2 - Inputs reflect quoted prices for identical assets or liabilities in
markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that
are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by
correlation or other means.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 11pt"&gt;
  &lt;tr&gt;
    &lt;td style="width: 3%; vertical-align: top"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2022;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="width: 97%; vertical-align: top"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level 3 - Unobservable inputs reflecting the Company&#x2019;s assumptions incorporated
in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions
that are reasonably available.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The carrying amounts of the Company&#x2019;s financial assets and liabilities,
such as cash, other receivables, accounts payable &amp;amp; accrued expenses, due to related party, notes payable and notes payables, approximate
their fair values because of the short maturity of these instruments. The Company's convertible notes payable are measured at amortized
cost.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Warrant and option expense was measured by using level 3 valuation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--DerivativesEmbeddedDerivatives_z1wlP3Af2xZa" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Embedded Conversion Features&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company evaluates embedded conversion features within convertible debt under
ASC 815 &#x201c;Derivatives and Hedging&#x201d; to determine whether the embedded conversion feature(s) should be bifurcated from the host
instrument and accounted for as a derivative at fair value with changes in fair value recorded in earnings. If the conversion feature
does not require derivative treatment under ASC 815, the instrument is evaluated under ASC 470-20 &#x201c;Debt with Conversion and Other
Options&#x201d; for consideration of any beneficial conversion feature.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_ztXdYHNdMxAj" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Recent Accounting Pronouncements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has reviewed all recently issued, but not yet effective, accounting
pronouncements, and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its
financial condition or the results of its operations.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

</us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2025-01-01to2025-03-31" id="Fact000257">&lt;p id="xdx_847_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zyvxh8hzvFR" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Description of Business&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On March 26, 2026 the Company changed its name from Worlds Inc. to Gemaxel Inc.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On May 16, 2011, the Company transferred, through a spin-off to its then wholly
owned subsidiary, Worlds Online Inc. (currently called MariMed Inc.), the majority of its operations and related operational assets.
The Company retained its patent portfolio and its legacy celebrity worlds and its collection of non-fungible tokens.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="From2025-01-01to2025-03-31" id="Fact000259">&lt;p id="xdx_848_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_znwWO7fImrze" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The accompanying financial statements have been prepared in conformity with
accounting principles generally accepted in the United States of America ("US GAAP"). The Company has incurred significant losses since
its inception and has had minimal revenues from operations. The Company will require substantial additional funds for its expansion of
its legacy celebrity worlds and its collection of non-fungible tokens. There can be no assurance that the Company will be able to obtain
the substantial additional capital resources to pursue its business plan or that any assumptions relating to its business plan will prove
to be accurate. The Company has not been able to generate sufficient revenue or obtain sufficient financing which has had a material
adverse effect on the Company, including requiring the Company to reduce operations. As the Company has focused its attention historically
on increasing its patent portfolio and enforcing it, and more recently on its expansion of its legacy celebrity worlds and its collection
of non-fungible tokens, the Company has been operating at a reduced capacity, with only one employee and using consultants to perform
any additional work that may be required.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2025-01-01to2025-03-31" id="Fact000261">&lt;p id="xdx_844_eus-gaap--UseOfEstimates_zpOmKIvdbOxj" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The preparation of financial statements in conformity with US GAAP requires
management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent
assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting
period. Actual results could differ from these estimates.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span style="font-size: 4pt"&gt;&#160;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2025-01-01to2025-03-31" id="Fact000263">&lt;p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z9tmwyUNZeLj" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Cash and Cash Equivalents&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash and cash equivalents include highly liquid money market instruments, which
have original maturities of three months or less at the time of purchase.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2025-01-01to2025-03-31" id="Fact000265">&lt;p id="xdx_845_eus-gaap--RevenueRecognitionPolicyTextBlock_zNCMfFx77Rbd" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Revenue Recognition&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Effective January 1, 2018, the Company adopted ASC 606. There was no impact
in adopting ASC 606 as the Company has no revenue at this time. In the second quarter of 2011, the Company spun off its online businesses
to MariMed Inc. The Company&#x2019;s sources of revenue after the spinoff was expected to be from sublicenses of the patented technology
by Worlds Online and any revenue that may be generated from enforcing its patents. Commencing in the first half of 2023, the Company
expects that its revenues will come from its sales of it&#x2019;s intellectual properties. The Company recognizes revenue by applying
the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine
the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when
each performance obligation is satisfied.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="From2025-01-01to2025-03-31" id="Fact000267">&lt;p id="xdx_848_eus-gaap--AdvertisingCostsPolicyTextBlock_zEMR8ua09pI4" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Advertising Expenses&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Advertising costs are expensed as incurred. There were &lt;span id="xdx_90E_eus-gaap--AdvertisingExpense_do_c20250101__20250331_zGg7C0T1jUL4" title="Advertising cost"&gt;&lt;span id="xdx_905_eus-gaap--AdvertisingExpense_do_c20240101__20240331_z3usRslWmln8" title="Advertising cost"&gt;no&lt;/span&gt;&lt;/span&gt; advertising costs
in the three months ended March 31, 2025 and 2024.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="Fact000269"
      unitRef="USD">0</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="From2024-01-012024-03-31"
      decimals="0"
      id="Fact000271"
      unitRef="USD">0</us-gaap:AdvertisingExpense>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2025-01-01to2025-03-31" id="Fact000273">&lt;p id="xdx_848_eus-gaap--ResearchAndDevelopmentExpensePolicy_zSBwhDjeLiff" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Research and Development Costs&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Research and development costs are charged to operations as incurred.&#160;There
were &lt;span id="xdx_907_eus-gaap--ResearchAndDevelopmentExpense_do_c20250101__20250331_zATOAWj7oosh" title="Research and development costs"&gt;&lt;span id="xdx_90E_eus-gaap--ResearchAndDevelopmentExpense_do_c20240101__20240331_zJbEHnFORAe9" title="Research and development costs"&gt;no&lt;/span&gt;&lt;/span&gt; research and development costs in the three months ended March 31, 2025 and 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="Fact000275"
      unitRef="USD">0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-012024-03-31"
      decimals="0"
      id="Fact000277"
      unitRef="USD">0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ReceivablesAndPortionsOfSecuritizationsThatCanBePrepaidAtPotentialLossPolicyPolicyTextBlock contextRef="From2025-01-01to2025-03-31" id="Fact000279">&lt;p id="xdx_846_eus-gaap--ReceivablesAndPortionsOfSecuritizationsThatCanBePrepaidAtPotentialLossPolicyPolicyTextBlock_zDnbm7a0y6na" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Prepaid Expenses&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Prepaid expenses is an annual fee paid to the OTC which is being amortized over
the life of the subscription. The balance at March 31, 2025 is $&lt;span id="xdx_90F_eus-gaap--PrepaidExpenseCurrent_iI_c20250331_zIGbcor3ZtDl" title="Prepaid expenses"&gt;6,563&lt;/span&gt;. The balance at December 31, 2024 is $&lt;span id="xdx_902_eus-gaap--PrepaidExpenseCurrent_iI_c20241231_z39PKCcKyYbb" title="Prepaid expenses"&gt;8,750&lt;/span&gt;.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ReceivablesAndPortionsOfSecuritizationsThatCanBePrepaidAtPotentialLossPolicyPolicyTextBlock>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000281"
      unitRef="USD">6563</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000283"
      unitRef="USD">8750</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2025-01-01to2025-03-31" id="Fact000285">&lt;p id="xdx_848_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z51XNCzD3qga" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Property and Equipment&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Property and equipment are stated at cost. Depreciation is provided on a straight
line basis over the estimated useful lives of the assets ranging from &lt;span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20250331__srt--RangeAxis__srt--MinimumMember_zCOBdbbhNJG3" title="Assets estimated useful lives::XDX::P3Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0287"&gt;three&lt;/span&gt;&lt;/span&gt; to &lt;span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20250331__srt--RangeAxis__srt--MaximumMember_zW6VPUZ0lCVd" title="Assets estimated useful lives::XDX::P5Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0289"&gt;five&lt;/span&gt;&lt;/span&gt; years. When assets are retired or disposed of, the
cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income. Maintenance
and repairs are charged to expense in the period incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2025-01-01to2025-03-31" id="Fact000291">&lt;p id="xdx_841_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zZGUvM4e1FXk" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Impairment of Long-Lived Assets&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company evaluates the recoverability of its fixed assets and other assets
in accordance with section 360-10-15 of the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification
(&#x201c;ASC&#x201d;) for disclosures about Impairment or Disposal of Long-Lived Assets. Disclosure requires recognition of impairment
of long-lived assets in the event the net book value of such assets exceeds its expected cash flows. If so, it is considered to be impaired
and is written down to fair value, which is determined based on either discounted future cash flows or appraised values. The Company
adopted the statement on inception. No impairments of these types of assets were recognized during the first quarter of 2025 and 2024.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="From2025-01-01to2025-03-31" id="Fact000293">&lt;p id="xdx_845_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zhKSXTyVwQfb" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 4pt"&gt;&#160;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Stock-Based
Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company accounts for stock-based compensation using the fair value method
following the guidance set forth in section 718-10 of the FASB ASC for disclosure about Stock-Based Compensation. This section requires
a public entity to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date
fair value of the award (with limited exceptions). That cost will be recognized over the period during which an employee is required
to provide services in exchange for the award (usually the vesting period). No compensation cost is recognized for equity instruments
for which employees do not render the requisite service.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2025-01-01to2025-03-31" id="Fact000295">&lt;p id="xdx_84F_eus-gaap--IncomeTaxPolicyTextBlock_zHIi1QhXCaG4" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Income Taxes&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company accounts for income taxes under Section 740-10-30 of the FASB ASC.
Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax basis of assets
and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.
Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets
will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in
the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities
of a change in tax rates is recognized in the consolidated statements of operations in the period that includes the enactment date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;ASC 740 prescribes a comprehensive model for how companies should recognize,
measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under
ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be
sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount
of tax benefit that has a greater than &lt;span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxSettlements_dp_c20250101__20250331_zOFfIVKxjVDa" title="Measured tax benefits"&gt;50&lt;/span&gt;% likelihood of being realized upon ultimate settlement with the tax authority assuming full
knowledge of the position and relevant facts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlements
      contextRef="From2025-01-01to2025-03-31"
      decimals="INF"
      id="Fact000297"
      unitRef="Pure">0.50</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlements>
    <us-gaap:ShortTermDebtTextBlock contextRef="From2025-01-01to2025-03-31" id="Fact000299">&lt;p id="xdx_84D_eus-gaap--ShortTermDebtTextBlock_z7CxHKZfsdji" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes Payable&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has $&lt;span id="xdx_909_eus-gaap--NotesPayableCurrent_iI_c20250331_zbYFujCBvTZh" title="Short terms notes"&gt;&lt;span id="xdx_90D_eus-gaap--NotesPayableCurrent_iI_c20241231_zzUVpTuevNc7" title="Short terms notes"&gt;773,279&lt;/span&gt;&lt;/span&gt; in short term notes outstanding at March 31, 2025 and
December 31, 2024. These are old notes payable for which the statute of limitations has passed and therefore the Company does not expect
it will ever have to repay those notes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

</us-gaap:ShortTermDebtTextBlock>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000301"
      unitRef="USD">773279</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000303"
      unitRef="USD">773279</us-gaap:NotesPayableCurrent>
    <us-gaap:LoanCommitmentsPolicy contextRef="From2025-01-01to2025-03-31" id="Fact000305">&lt;p id="xdx_84B_eus-gaap--LoanCommitmentsPolicy_zPhjO4aEoaBg" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Loan
Payable Related Party&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company received a loan during the quarter from its CEO to pay operating
expenses. The balance at March 31, 2025 is $&lt;span id="xdx_906_eus-gaap--LoansPayableCurrent_iI_c20250331_z0qhm4Xq3hGl" title="CEO loan"&gt;4,500&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LoanCommitmentsPolicy>
    <us-gaap:LoansPayableCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000307"
      unitRef="USD">4500</us-gaap:LoansPayableCurrent>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2025-01-01to2025-03-31" id="Fact000309">&lt;p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_zIcTLO5xmcQf" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Loss Per Share&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net loss per common share is computed pursuant to section 260-10-45 of the FASB
ASC. Basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during
the period. As of March 31, 2025, there were &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20250331_zE3nM751mIuh" title="Options"&gt;1,600,000&lt;/span&gt; options and &lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_do_c20240331_zIyqudo5bffg" title="Outstanding warrants"&gt;no&lt;/span&gt; warrants outstanding and as of March 31, 2024, there were &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240331_zQe9bz4jdy0f" title="Options"&gt;16,600,000&lt;/span&gt;
options and &lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_do_c20250331__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--AntidilutiveSecuritiesNameDomain_ztatvmh4pxKh" title=" Warrants outstanding"&gt;&lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_do_c20240331__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--AntidilutiveSecuritiesNameDomain_zzmXGFMkzXQf" title=" Warrants outstanding"&gt;no&lt;/span&gt;&lt;/span&gt; warrants outstanding whose effect is anti-dilutive and not included in diluted net loss per share for March 31, 2025 or
for March 31, 2024. The options and warrants may dilute future earnings per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="Fact000311"
      unitRef="Shares">1600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-03-31"
      decimals="INF"
      id="Fact000313"
      unitRef="Shares">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-03-31"
      decimals="INF"
      id="Fact000315"
      unitRef="Shares">16600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-03-31_us-gaap_AntidilutiveSecuritiesNameDomain"
      decimals="INF"
      id="Fact000317"
      unitRef="Shares">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-03-31_us-gaap_AntidilutiveSecuritiesNameDomain"
      decimals="INF"
      id="Fact000319"
      unitRef="Shares">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="From2025-01-01to2025-03-31" id="Fact000321">&lt;p id="xdx_846_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zbk0tvaLiKNa" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Commitments and Contingencies&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company follows subtopic 450-20 of the FASB ASC to report accounting for
contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company
but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities,
and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are
pending against the Company or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any
legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 4pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;If the assessment of a contingency indicates that it is probable that a material
loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company&#x2019;s
financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible,
or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses,
if determinable and material, would be disclosed.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loss contingencies considered remote are generally not disclosed unless they
involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at
this time, that these matters will have a material adverse effect on the Company&#x2019;s financial position, results of operations or
cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company&#x2019;s business, financial
position, and results of operations or cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;During 2000 the Company was involved in a lawsuit relating to unpaid consulting
services. In April, 2001 a judgment against the Company was rendered for approximately $&lt;span id="xdx_90B_eus-gaap--LitigationReserveNoncurrent_iI_c20010401_zIONT3hvGtfc" title="Judgment amount"&gt;205,000&lt;/span&gt;. As of March 31, 2025, and December 31,
2024 the Company recorded a reserve of $&lt;span id="xdx_906_eus-gaap--LitigationReserve_iI_c20250331_z7uyhYqYw329" title="Reserve for lawsuit"&gt;&lt;span id="xdx_904_eus-gaap--LitigationReserve_iI_c20241231_zyAQHdiDmsNe" title="Reserve for lawsuit"&gt;205,000&lt;/span&gt;&lt;/span&gt; for this lawsuit, which is included in accrued expenses in the accompanying balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="AsOf2001-04-01"
      decimals="0"
      id="Fact000323"
      unitRef="USD">205000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:LitigationReserve
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000325"
      unitRef="USD">205000</us-gaap:LitigationReserve>
    <us-gaap:LitigationReserve
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000327"
      unitRef="USD">205000</us-gaap:LitigationReserve>
    <us-gaap:UnusualRisksAndUncertaintiesTextBlock contextRef="From2025-01-01to2025-03-31" id="Fact000329">&lt;p id="xdx_84C_eus-gaap--UnusualRisksAndUncertaintiesTextBlock_z8iMXKoJq3Gh" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Risk and Uncertainties&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company is subject to risks common to companies in the technology industries,
including, but not limited to, litigation, development of new technological innovations and dependence on key personnel.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UnusualRisksAndUncertaintiesTextBlock>
    <us-gaap:OffBalanceSheetCreditExposurePolicyPolicyTextBlock contextRef="From2025-01-01to2025-03-31" id="Fact000331">&lt;p id="xdx_847_eus-gaap--OffBalanceSheetCreditExposurePolicyPolicyTextBlock_zj19VIoymAQ1" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Off Balance Sheet Arrangements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company does not have any off-balance sheet arrangements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:OffBalanceSheetCreditExposurePolicyPolicyTextBlock>
    <us-gaap:IncomeTaxUncertaintiesPolicy contextRef="From2025-01-01to2025-03-31" id="Fact000333">&lt;p id="xdx_84C_eus-gaap--IncomeTaxUncertaintiesPolicy_zQAQSOFCVGMa" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Uncertain Tax Positions&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company did not take any uncertain tax positions and had no adjustments
to unrecognized income tax liabilities or benefits pursuant to the provisions of Section 740-10-25 for the year ended December 31, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxUncertaintiesPolicy>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2025-01-01to2025-03-31" id="Fact000335">&lt;p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z9JkpjgAZ875" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Fair Value of Financial Instruments&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company measures assets and liabilities at fair value based on an expected
exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on
the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such,
fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance
on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby
inputs, used in valuation techniques, are assigned a hierarchical level.&lt;span style="font-size: 4pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;



&lt;p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 4pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The following are the hierarchical levels of inputs to measure fair value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 11pt"&gt;
  &lt;tr&gt;
    &lt;td style="width: 3%; vertical-align: top"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2022;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="width: 97%; vertical-align: top"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level 1 - Observable inputs that reflect quoted market prices in active markets
for identical assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 11pt"&gt;
  &lt;tr&gt;
    &lt;td style="width: 3%; vertical-align: top"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2022;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="width: 97%; vertical-align: top"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level 2 - Inputs reflect quoted prices for identical assets or liabilities in
markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that
are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by
correlation or other means.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 11pt"&gt;
  &lt;tr&gt;
    &lt;td style="width: 3%; vertical-align: top"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2022;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="width: 97%; vertical-align: top"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level 3 - Unobservable inputs reflecting the Company&#x2019;s assumptions incorporated
in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions
that are reasonably available.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The carrying amounts of the Company&#x2019;s financial assets and liabilities,
such as cash, other receivables, accounts payable &amp;amp; accrued expenses, due to related party, notes payable and notes payables, approximate
their fair values because of the short maturity of these instruments. The Company's convertible notes payable are measured at amortized
cost.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Warrant and option expense was measured by using level 3 valuation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:DerivativesEmbeddedDerivatives contextRef="From2025-01-01to2025-03-31" id="Fact000337">&lt;p id="xdx_843_eus-gaap--DerivativesEmbeddedDerivatives_z1wlP3Af2xZa" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Embedded Conversion Features&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company evaluates embedded conversion features within convertible debt under
ASC 815 &#x201c;Derivatives and Hedging&#x201d; to determine whether the embedded conversion feature(s) should be bifurcated from the host
instrument and accounted for as a derivative at fair value with changes in fair value recorded in earnings. If the conversion feature
does not require derivative treatment under ASC 815, the instrument is evaluated under ASC 470-20 &#x201c;Debt with Conversion and Other
Options&#x201d; for consideration of any beneficial conversion feature.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DerivativesEmbeddedDerivatives>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2025-01-01to2025-03-31" id="Fact000339">&lt;p id="xdx_84D_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_ztXdYHNdMxAj" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Recent Accounting Pronouncements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has reviewed all recently issued, but not yet effective, accounting
pronouncements, and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its
financial condition or the results of its operations.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2025-01-01to2025-03-31" id="Fact000341">&lt;p id="xdx_802_eus-gaap--DebtDisclosureTextBlock_zaxDeptIqoFb" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 3 - &lt;span id="xdx_82B_zVBEGhXlDUNa"&gt;NOTES PAYABLE&lt;/span&gt;&lt;/b&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zly01ZTtcw4c" style="width: 100%; border-collapse: collapse; font-size: 11pt" summary="xdx: Disclosure - Notes Payable - (Details)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_916_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_z9dQyJGVgvLl"&gt;Notes payable at March 31, 2025&lt;/span&gt; consist of the following:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_492_20250331_zh39gg79fq1d" style="vertical-align: bottom"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--NotesPayable_iI_zh8nH7gNbcWk"&gt;
    &lt;td style="width: 65%; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unsecured note payable bearing 8% interest, entire balance of principal and
unpaid interest due on demand&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="width: 4%; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="width: 30%; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;124,230&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="width: 0%; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--NotesAndLoansPayable_iI_zoWEhEfSTEUl"&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unsecured note payable bearing 10% interest, entire balance of principal and
unpaid interest due on demand&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;649,049&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--NotesPayableCurrent_iI_zKbwUbTyJeih"&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="border-bottom: Black 2.5pt double; font-size: 11pt; color: Black; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;p style="border-bottom: Black 2.5pt double; font-size: 11pt; color: Black; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;773,279&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths_iI_maNPCz2IB_zQe0Emxmr3j6"&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025 (9 months remaining)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;773,279&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--FinanceLeaseLiabilityPaymentsDueInRollingYearTwo_iI_maNPCz2IB_zNkQ475Xt8Aa"&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-
                                                                0 -&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--FinanceLeaseLiabilityPaymentsDueInRollingYearThree_iI_maNPCz2IB_zs3tSF8o8fmj"&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-
                                                                           0 -&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--FinanceLeaseLiabilityPaymentsDueInRollingYearFour_iI_maNPCz2IB_z2GsNcfziLe1"&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-
                                                                0 -&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--FinanceLeaseLiabilityPaymentsDueInRollingYearFive_iI_maNPCz2IB_zNvtZZ93kXUh"&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-
                                                                                                           0 -&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="border-bottom: Black 2.5pt double; font-size: 11pt; color: Black; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="border-bottom: Black 2.5pt double; font-size: 11pt; color: Black; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;773,279&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company accrued interest of $&lt;span id="xdx_90B_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20250101__20250331_zqPD6q6LdeZa" title="Accured interest on notes"&gt;18,738&lt;/span&gt; on the notes during the quarter ended
March 31, 2025.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock contextRef="From2025-01-01to2025-03-31" id="Fact000343">&lt;table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zly01ZTtcw4c" style="width: 100%; border-collapse: collapse; font-size: 11pt" summary="xdx: Disclosure - Notes Payable - (Details)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_916_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_z9dQyJGVgvLl"&gt;Notes payable at March 31, 2025&lt;/span&gt; consist of the following:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_492_20250331_zh39gg79fq1d" style="vertical-align: bottom"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--NotesPayable_iI_zh8nH7gNbcWk"&gt;
    &lt;td style="width: 65%; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unsecured note payable bearing 8% interest, entire balance of principal and
unpaid interest due on demand&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="width: 4%; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="width: 30%; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;124,230&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="width: 0%; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--NotesAndLoansPayable_iI_zoWEhEfSTEUl"&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unsecured note payable bearing 10% interest, entire balance of principal and
unpaid interest due on demand&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;649,049&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--NotesPayableCurrent_iI_zKbwUbTyJeih"&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="border-bottom: Black 2.5pt double; font-size: 11pt; color: Black; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;p style="border-bottom: Black 2.5pt double; font-size: 11pt; color: Black; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;773,279&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths_iI_maNPCz2IB_zQe0Emxmr3j6"&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025 (9 months remaining)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;773,279&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--FinanceLeaseLiabilityPaymentsDueInRollingYearTwo_iI_maNPCz2IB_zNkQ475Xt8Aa"&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-
                                                                0 -&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--FinanceLeaseLiabilityPaymentsDueInRollingYearThree_iI_maNPCz2IB_zs3tSF8o8fmj"&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-
                                                                           0 -&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--FinanceLeaseLiabilityPaymentsDueInRollingYearFour_iI_maNPCz2IB_z2GsNcfziLe1"&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-
                                                                0 -&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--FinanceLeaseLiabilityPaymentsDueInRollingYearFive_iI_maNPCz2IB_zNvtZZ93kXUh"&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-
                                                                                                           0 -&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="border-bottom: Black 2.5pt double; font-size: 11pt; color: Black; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="border-bottom: Black 2.5pt double; font-size: 11pt; color: Black; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;773,279&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: White"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:NotesPayable
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000346"
      unitRef="USD">124230</us-gaap:NotesPayable>
    <us-gaap:NotesAndLoansPayable
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000348"
      unitRef="USD">649049</us-gaap:NotesAndLoansPayable>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000350"
      unitRef="USD">773279</us-gaap:NotesPayableCurrent>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000352"
      unitRef="USD">773279</us-gaap:FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueInRollingYearTwo
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000354"
      unitRef="USD">-0</us-gaap:FinanceLeaseLiabilityPaymentsDueInRollingYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueInRollingYearThree
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000356"
      unitRef="USD">-0</us-gaap:FinanceLeaseLiabilityPaymentsDueInRollingYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueInRollingYearFour
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000358"
      unitRef="USD">-0</us-gaap:FinanceLeaseLiabilityPaymentsDueInRollingYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueInRollingYearFive
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000360"
      unitRef="USD">-0</us-gaap:FinanceLeaseLiabilityPaymentsDueInRollingYearFive>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="Fact000362"
      unitRef="USD">18738</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock contextRef="From2025-01-01to2025-03-31" id="Fact000364">&lt;p id="xdx_800_eus-gaap--ShareholdersEquityAndShareBasedPaymentsTextBlock_zvDINFSJXHn7" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE
4 - &lt;span id="xdx_82C_zZkSD0AJtIBk"&gt;EQUITY&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company did not issue any shares of common stock, options or warrants in the three months ending March 31, 2025 or in the three months
ending March 31, 2024.&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z82uDtH5yQIk" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock Warrants and Options (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" id="xdx_488_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_zZIhvERVfKM8" style="font-size: 11pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_48C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_zCGyyi22Vmsc"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_489_ecustom--RemainingLifeInYears_iI_znZc0NjujSGd"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="font-size: 11pt"&gt;&lt;/td&gt;&lt;td colspan="5" style="text-align: center"&gt;&lt;span id="xdx_915_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zjt6QwBwoSCe"&gt;Stock Warrants and Options&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="11" style="font: 11pt Times New Roman, Times, Serif; text-align: center"&gt;Stock warrants/options outstanding and exercisable on March 31, 2025 are as follows&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="font: 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="font-size: 11pt; text-align: center"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="text-decoration: underline solid; font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_911_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_zScPQkBjDcQ1"&gt;Exercise Price per Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-size: 11pt; text-align: center"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="text-decoration: underline solid; font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_916_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_zADZ7356vaUf"&gt;Shares Under Option/warrant&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-size: 11pt; text-align: center"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="text-decoration: underline solid; font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_91B_ecustom--RemainingLifeInYears_zLt3FdZjCml4"&gt;Remaining Life in Years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="font-size: 11pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-size: 11pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-size: 11pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="3" style="font-size: 11pt"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_411_20250331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Outstanding1Member_zjyovmO4KzXb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 1%; font-size: 11pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 26%; font-size: 11pt; text-align: right"&gt;0.27&lt;/td&gt;&lt;td style="width: 1%; font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 26%; font-size: 11pt; text-align: right"&gt;300,000&lt;/td&gt;&lt;td style="width: 1%; font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 26%; font-size: 11pt; text-align: right"&gt;0.63&lt;/td&gt;&lt;td style="width: 1%; font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_414_20250331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Outstanding2Member_zkgYOrfXXtOl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;0.05&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;600,000&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;1.76&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41E_20250331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Outstanding3Member_zAZ5mZ8qhVKf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;0.08&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;700,000&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;1.88&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="font-size: 11pt; text-align: left"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/p&gt;

&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20250331_zePWFefhh0m3" title="Total option/warrant outstanding"&gt;1,600,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="font-size: 11pt; text-align: left"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercisable&lt;/span&gt;&lt;/p&gt;

&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41A_20250331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Exercisable1Member_z9zKYJWAG7Jd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;0.27&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;300,000&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;0.63&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_417_20250331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Exercisable2Member_zhPYj6ozqBE5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;0.05&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;600,000&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;1.76&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41A_20250331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Exercisable3Member_zhqOxAX1vUse" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;0.08&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;700,000&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;1.88&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="font-size: 11pt; text-align: left"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/p&gt;

&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20250331_z9hJZuS9w0W7" title="Total option/warrants exercisable"&gt;1,600,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2025-01-01to2025-03-31" id="Fact000366">&lt;table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z82uDtH5yQIk" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock Warrants and Options (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" id="xdx_488_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_zZIhvERVfKM8" style="font-size: 11pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_48C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_zCGyyi22Vmsc"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_489_ecustom--RemainingLifeInYears_iI_znZc0NjujSGd"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="font-size: 11pt"&gt;&lt;/td&gt;&lt;td colspan="5" style="text-align: center"&gt;&lt;span id="xdx_915_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zjt6QwBwoSCe"&gt;Stock Warrants and Options&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="11" style="font: 11pt Times New Roman, Times, Serif; text-align: center"&gt;Stock warrants/options outstanding and exercisable on March 31, 2025 are as follows&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="font: 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="font-size: 11pt; text-align: center"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="text-decoration: underline solid; font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_911_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_zScPQkBjDcQ1"&gt;Exercise Price per Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-size: 11pt; text-align: center"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="text-decoration: underline solid; font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_916_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_zADZ7356vaUf"&gt;Shares Under Option/warrant&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-size: 11pt; text-align: center"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="text-decoration: underline solid; font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_91B_ecustom--RemainingLifeInYears_zLt3FdZjCml4"&gt;Remaining Life in Years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="font-size: 11pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-size: 11pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-size: 11pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="3" style="font-size: 11pt"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_411_20250331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Outstanding1Member_zjyovmO4KzXb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 1%; font-size: 11pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 26%; font-size: 11pt; text-align: right"&gt;0.27&lt;/td&gt;&lt;td style="width: 1%; font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 26%; font-size: 11pt; text-align: right"&gt;300,000&lt;/td&gt;&lt;td style="width: 1%; font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 26%; font-size: 11pt; text-align: right"&gt;0.63&lt;/td&gt;&lt;td style="width: 1%; font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_414_20250331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Outstanding2Member_zkgYOrfXXtOl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;0.05&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;600,000&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;1.76&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41E_20250331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Outstanding3Member_zAZ5mZ8qhVKf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;0.08&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;700,000&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;1.88&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="font-size: 11pt; text-align: left"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/p&gt;

&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20250331_zePWFefhh0m3" title="Total option/warrant outstanding"&gt;1,600,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="font-size: 11pt; text-align: left"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercisable&lt;/span&gt;&lt;/p&gt;

&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41A_20250331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Exercisable1Member_z9zKYJWAG7Jd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;0.27&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;300,000&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;0.63&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_417_20250331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Exercisable2Member_zhPYj6ozqBE5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;0.05&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;600,000&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;1.76&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41A_20250331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Exercisable3Member_zhqOxAX1vUse" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;0.08&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;700,000&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;1.88&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="font-size: 11pt; text-align: left"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/p&gt;

&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20250331_z9hJZuS9w0W7" title="Total option/warrants exercisable"&gt;1,600,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2025-03-31_custom_Outstanding1Member"
      decimals="INF"
      id="Fact000371"
      unitRef="USDPShares">0.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2025-03-31_custom_Outstanding1Member"
      decimals="INF"
      id="Fact000372"
      unitRef="Shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <WDDD:RemainingLifeInYears
      contextRef="AsOf2025-03-31_custom_Outstanding1Member"
      decimals="INF"
      id="Fact000373"
      unitRef="Pure">0.63</WDDD:RemainingLifeInYears>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2025-03-31_custom_Outstanding2Member"
      decimals="INF"
      id="Fact000374"
      unitRef="USDPShares">0.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2025-03-31_custom_Outstanding2Member"
      decimals="INF"
      id="Fact000375"
      unitRef="Shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <WDDD:RemainingLifeInYears
      contextRef="AsOf2025-03-31_custom_Outstanding2Member"
      decimals="INF"
      id="Fact000376"
      unitRef="Pure">1.76</WDDD:RemainingLifeInYears>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2025-03-31_custom_Outstanding3Member"
      decimals="INF"
      id="Fact000377"
      unitRef="USDPShares">0.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2025-03-31_custom_Outstanding3Member"
      decimals="INF"
      id="Fact000378"
      unitRef="Shares">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <WDDD:RemainingLifeInYears
      contextRef="AsOf2025-03-31_custom_Outstanding3Member"
      decimals="INF"
      id="Fact000379"
      unitRef="Pure">1.88</WDDD:RemainingLifeInYears>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="Fact000381"
      unitRef="Shares">1600000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2025-03-31_custom_Exercisable1Member"
      decimals="INF"
      id="Fact000382"
      unitRef="USDPShares">0.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2025-03-31_custom_Exercisable1Member"
      decimals="INF"
      id="Fact000383"
      unitRef="Shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <WDDD:RemainingLifeInYears
      contextRef="AsOf2025-03-31_custom_Exercisable1Member"
      decimals="INF"
      id="Fact000384"
      unitRef="Pure">0.63</WDDD:RemainingLifeInYears>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2025-03-31_custom_Exercisable2Member"
      decimals="INF"
      id="Fact000385"
      unitRef="USDPShares">0.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2025-03-31_custom_Exercisable2Member"
      decimals="INF"
      id="Fact000386"
      unitRef="Shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <WDDD:RemainingLifeInYears
      contextRef="AsOf2025-03-31_custom_Exercisable2Member"
      decimals="INF"
      id="Fact000387"
      unitRef="Pure">1.76</WDDD:RemainingLifeInYears>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2025-03-31_custom_Exercisable3Member"
      decimals="INF"
      id="Fact000388"
      unitRef="USDPShares">0.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2025-03-31_custom_Exercisable3Member"
      decimals="INF"
      id="Fact000389"
      unitRef="Shares">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <WDDD:RemainingLifeInYears
      contextRef="AsOf2025-03-31_custom_Exercisable3Member"
      decimals="INF"
      id="Fact000390"
      unitRef="Pure">1.88</WDDD:RemainingLifeInYears>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="Fact000392"
      unitRef="Shares">1600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2025-01-01to2025-03-31" id="Fact000394">&lt;p id="xdx_80B_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zwtqlNYBLAS6" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 5 - &lt;span id="xdx_82A_zWMU6eVJg8D5"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company is committed to an employment agreement with its President and CEO, Thom Kidrin. The agreement, dated as of August 28, 2018,
is for &lt;span id="xdx_902_ecustom--TermsOfEmploymentAgreement_iI_dc_uYears_c20190828_zV8nt0c485ea" title="Employee contract terms"&gt;five&lt;/span&gt;
years with a &lt;span id="xdx_909_ecustom--TermsOfEmploymentAgreementRenewalOption_iI_dc_uYears_c20190828_zN5hOF8In57a" title="Employment renewal option"&gt;one&lt;/span&gt;-year
renewal option held by Mr. Kidrin.&#160; Prior to its expiration, Mr. Kidrin agreed to a second &lt;span id="xdx_90F_ecustom--EmployeeExtension_c20250101__20250331_zXTCeJ3KW2Hh" title="CEO employee extended"&gt;one-year extension&lt;/span&gt; of his employment agreement. The agreement provides for a base salary of &lt;span id="xdx_900_ecustom--OfficerBaseSalary_iI_c20190828_zwOKdrjS2yq5"&gt;$200,000&lt;/span&gt;,
which increases &lt;span id="xdx_902_eus-gaap--DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_iI_uPure_c20190828_zdrg67ilM9c8" title="Annual base salary increase"&gt;10%&lt;/span&gt;
on September 1 of each year; a monthly car allowance of &lt;span id="xdx_901_ecustom--CarAllowance_iI_c20190828_z8UTlTtMUCw2"&gt;$500&lt;/span&gt;;
an annual bonus equal to &lt;span id="xdx_900_ecustom--AnnuaBonus_iI_c20190828_zXo0Mz1xo8Ih" title="Annual bonus percentage"&gt;2.5%&lt;/span&gt;
of Pre-Tax Income (as defined in the agreement); an additional bonus as follows: &lt;span id="xdx_901_ecustom--AdditionalBonus_iI_c20190828_zB6AYynaTOpi"&gt;$75,000&lt;/span&gt;,
if Pre-Tax Income for the year is between &lt;span id="xdx_90F_ecustom--PretaxIncomeRangeLower_iI_dp_c20190828_ztjsBma8wz6h"&gt;150%&lt;/span&gt;
and &lt;span id="xdx_902_ecustom--PretaxIncomeRangeHigher_iI_uPure_c20190828_zTzkaXEYJSd"&gt;200%&lt;/span&gt; of the prior fiscal year&#x2019;s
Pre-Tax Income or (B) &lt;span id="xdx_905_ecustom--AdditionalBonus_iI_c20190828__dei--LegalEntityAxis__custom--Additionalbonus1Member_zfup3fSsDXk4"&gt;$100,000&lt;/span&gt;,
if Pre-Tax Income for the year is between &lt;span id="xdx_909_ecustom--PretaxIncomeRangeLower_iI_uPure_c20190828__dei--LegalEntityAxis__custom--Additionalbonus1Member_z4tcFLqcgoV5"&gt;201%&lt;/span&gt;
and &lt;span id="xdx_904_ecustom--PretaxIncomeRangeHigher_iI_uPure_c20190828__dei--LegalEntityAxis__custom--Additionalbonus1Member_zy4DSoq82Tvj"&gt;250%&lt;/span&gt;
of the prior fiscal year&#x2019;s Pre-Tax Income or (C) &lt;span id="xdx_903_ecustom--AdditionalBonus_iI_c20190828__dei--LegalEntityAxis__custom--Additionalbonus2Member_zj8cEEIQhPBg"&gt;$200,000&lt;/span&gt;,
if Pre-Tax Income for the year is &lt;span id="xdx_90A_ecustom--PretaxIncomeRange_iI_uPure_c20190828__dei--LegalEntityAxis__custom--Additionalbonus2Member_zewmFllnoVW4"&gt;251%&lt;/span&gt;
or greater than the prior fiscal year&#x2019;s Pre-Tax Income, but in no event shall this additional bonus exceed five (&lt;span id="xdx_902_ecustom--AdditionalBonusExceed_iI_c20190828_zSWAgxXVgnz9" title="Additional bonus maxium amount"&gt;5%&lt;/span&gt;)
percent of Pre-Tax Income for such year; payment of up to &lt;span id="xdx_90A_eus-gaap--LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid_iI_c20190828_zDZsFDteM8u5" title="Life insuance premiums"&gt;$10,000&lt;/span&gt;
in life insurance premiums; options to purchase &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_dm_c20190828__20190829_zxUh2Q3ljKob" title="Number of shares to purchase"&gt;5
million&lt;/span&gt; shares of Worlds Inc. common stock at an exercise price of&#160; &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20190828_zae3PkrYMlh7" title="Common stock exercise price"&gt;$0.25&lt;/span&gt;
per share, &lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_dm_c20180828_zBnrVAjtlOA5" title="Vested shares to purchase"&gt;2
million&lt;/span&gt; of which vested on August 28, 2018, &lt;span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber1_iI_pp5d_dm_c20190828_zrdIaGFnVlD8" title="Vested shares to purchase"&gt;1.5
million&lt;/span&gt; vested on August 28, 2019 and the remaining &lt;span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber1_iI_pp5d_dm_c20200828_zCE99w1CHV1e" title="Vested shares"&gt;1.5
million&lt;/span&gt; vested on August 28, 2020 and a death benefit of at least $&lt;span id="xdx_90E_eus-gaap--LifeSettlementContractsFairValueMethodFaceValue_iI_dm_c20190828_zo2z9CJgHXm7" title="Death benefit"&gt;2
million&lt;/span&gt; dollars; and a payment equal to &lt;span id="xdx_90E_ecustom--PaymentAmountBased_iI_c20190828_zloxTEeBnd67" title="Payment amount times base amount"&gt;2.99&lt;/span&gt;
times his base amount (as defined in the agreement) in the event of a Change of Control (as defined in the agreement).&#160; The
agreement also provides that Mr. Kidrin can be terminated for cause (as defined in the agreement) and that he is subject to
restrictive covenants for &lt;span id="xdx_907_ecustom--RestrictiveConvenantsAmount_iI_uInterger_c20190828_zjEGgv77aFXd" title="Restrictive convenants amount"&gt;12&lt;/span&gt;
months after termination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <WDDD:TermsOfEmploymentAgreement
      contextRef="AsOf2019-08-28"
      decimals="INF"
      id="Fact000396"
      unitRef="Years">5</WDDD:TermsOfEmploymentAgreement>
    <WDDD:TermsOfEmploymentAgreementRenewalOption
      contextRef="AsOf2019-08-28"
      decimals="INF"
      id="Fact000398"
      unitRef="Years">1</WDDD:TermsOfEmploymentAgreementRenewalOption>
    <WDDD:EmployeeExtension contextRef="From2025-01-01to2025-03-31" id="Fact000400">one-year extension</WDDD:EmployeeExtension>
    <WDDD:OfficerBaseSalary
      contextRef="AsOf2019-08-28"
      decimals="0"
      id="Fact000401"
      unitRef="USD">200000</WDDD:OfficerBaseSalary>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="AsOf2019-08-28"
      decimals="INF"
      id="Fact000403"
      unitRef="Pure">0.10</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <WDDD:CarAllowance
      contextRef="AsOf2019-08-28"
      decimals="0"
      id="Fact000404"
      unitRef="USD">500</WDDD:CarAllowance>
    <WDDD:AnnuaBonus
      contextRef="AsOf2019-08-28"
      decimals="INF"
      id="Fact000406"
      unitRef="Pure">0.025</WDDD:AnnuaBonus>
    <WDDD:AdditionalBonus
      contextRef="AsOf2019-08-28"
      decimals="0"
      id="Fact000407"
      unitRef="USD">75000</WDDD:AdditionalBonus>
    <WDDD:PretaxIncomeRangeLower
      contextRef="AsOf2019-08-28"
      decimals="INF"
      id="Fact000408"
      unitRef="Pure">1.50</WDDD:PretaxIncomeRangeLower>
    <WDDD:PretaxIncomeRangeHigher
      contextRef="AsOf2019-08-28"
      decimals="INF"
      id="Fact000409"
      unitRef="Pure">2</WDDD:PretaxIncomeRangeHigher>
    <WDDD:AdditionalBonus
      contextRef="AsOf2019-08-28_custom_Additionalbonus1Member"
      decimals="0"
      id="Fact000410"
      unitRef="USD">100000</WDDD:AdditionalBonus>
    <WDDD:PretaxIncomeRangeLower
      contextRef="AsOf2019-08-28_custom_Additionalbonus1Member"
      decimals="INF"
      id="Fact000411"
      unitRef="Pure">2.01</WDDD:PretaxIncomeRangeLower>
    <WDDD:PretaxIncomeRangeHigher
      contextRef="AsOf2019-08-28_custom_Additionalbonus1Member"
      decimals="INF"
      id="Fact000412"
      unitRef="Pure">2.50</WDDD:PretaxIncomeRangeHigher>
    <WDDD:AdditionalBonus
      contextRef="AsOf2019-08-28_custom_Additionalbonus2Member"
      decimals="0"
      id="Fact000413"
      unitRef="USD">200000</WDDD:AdditionalBonus>
    <WDDD:PretaxIncomeRange
      contextRef="AsOf2019-08-28_custom_Additionalbonus2Member"
      decimals="INF"
      id="Fact000414"
      unitRef="Pure">2.51</WDDD:PretaxIncomeRange>
    <WDDD:AdditionalBonusExceed
      contextRef="AsOf2019-08-28"
      decimals="INF"
      id="Fact000416"
      unitRef="Pure">0.05</WDDD:AdditionalBonusExceed>
    <us-gaap:LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid
      contextRef="AsOf2019-08-28"
      decimals="0"
      id="Fact000418"
      unitRef="USD">10000</us-gaap:LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
      contextRef="From2019-08-282019-08-29"
      decimals="INF"
      id="Fact000420"
      unitRef="Shares">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2019-08-28"
      decimals="INF"
      id="Fact000422"
      unitRef="USDPShares">0.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="AsOf2018-08-28"
      decimals="INF"
      id="Fact000424"
      unitRef="Shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <WDDD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber1
      contextRef="AsOf2019-08-28"
      decimals="5"
      id="Fact000426"
      unitRef="Shares">1500000</WDDD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber1>
    <WDDD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber1
      contextRef="AsOf2020-08-28"
      decimals="5"
      id="Fact000428"
      unitRef="Shares">1500000</WDDD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber1>
    <us-gaap:LifeSettlementContractsFairValueMethodFaceValue
      contextRef="AsOf2019-08-28"
      decimals="0"
      id="Fact000430"
      unitRef="USD">2000000</us-gaap:LifeSettlementContractsFairValueMethodFaceValue>
    <WDDD:PaymentAmountBased
      contextRef="AsOf2019-08-28"
      decimals="INF"
      id="Fact000432"
      unitRef="Pure">2.99</WDDD:PaymentAmountBased>
    <WDDD:RestrictiveConvenantsAmount
      contextRef="AsOf2019-08-28"
      decimals="INF"
      id="Fact000434"
      unitRef="Interger">12</WDDD:RestrictiveConvenantsAmount>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2025-01-01to2025-03-31" id="Fact000436">&lt;p id="xdx_80B_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zlCN5MeLub2f" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 6 - &lt;span id="xdx_823_zUuWHFu2Zcbh"&gt;RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;During the three months ended March 31, 2024, Mr. Kidrin, the CEO of the Company,
loaned the Company $&lt;span id="xdx_90A_eus-gaap--IncreaseDecreaseInNotesPayableCurrent_c20240101__20240331_zSQPt9sacUo5" title="CEO loan for operating expenses"&gt;4,500&lt;/span&gt; to cover operating expenses.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The balance in the accrued expense attributable to related parties is comprised
of accrued salary due the CEO based on an employment agreement for $&lt;span id="xdx_90C_eus-gaap--AccruedSalariesCurrent_iI_c20250331_z1is2Fzmn3T9" title="Accrued salary for CEO"&gt;288,577&lt;/span&gt;, a $&lt;span id="xdx_908_eus-gaap--IncreaseDecreaseInDueToRelatedPartiesCurrent_c20240101__20241231_z0gEpiOwHWsj" title="Increase in accured consulting fees"&gt;60,500&lt;/span&gt; increase from the December 31, 2024 balance and
an accrued consulting fee to the CFO in the amount of $&lt;span id="xdx_905_eus-gaap--AccruedProfessionalFeesCurrent_iI_c20250331_zMOV0nWLxs5a" title="Accrued consulting fee to CFO"&gt;96,188&lt;/span&gt;, an increase of $&lt;span id="xdx_908_eus-gaap--IncreaseDecreaseInDueToRelatedPartiesCurrent_c20250101__20250331_zHtQ42Shprdc" title="Increase in accured consulting fees"&gt;7,500&lt;/span&gt; in the three months ended March 31, 2025 for a total
of $&lt;span id="xdx_90B_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_c20250331_zr36gKGqYQPe" title="CFO accrued consulting fee"&gt;384,765&lt;/span&gt; at March 31, 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
balance in the accrued expense attributable to related parties at December 31, 2024 is comprised of accrued salary due the CEO based
on an employment agreement for $&lt;span id="xdx_90C_eus-gaap--AccruedSalariesCurrent_iI_c20241231_zzqP2ylXdQh6" title="Accrued salary for CEO"&gt;228,077&lt;/span&gt; and an accrued consulting fee to the CFO in the amount of $&lt;span id="xdx_908_eus-gaap--AccruedProfessionalFeesCurrent_iI_c20241231_zbhUWGxo8IY4" title="Accrued consulting fee to CFO"&gt;88,688&lt;/span&gt; for a total of $&lt;span id="xdx_905_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_c20241231_ze7XCqTnuoT3" title="CFO accrued consulting fee"&gt;316,765&lt;/span&gt; at
December 31, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:IncreaseDecreaseInNotesPayableCurrent
      contextRef="From2024-01-012024-03-31"
      decimals="0"
      id="Fact000438"
      unitRef="USD">4500</us-gaap:IncreaseDecreaseInNotesPayableCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000440"
      unitRef="USD">288577</us-gaap:AccruedSalariesCurrent>
    <us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000442"
      unitRef="USD">60500</us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000444"
      unitRef="USD">96188</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="Fact000446"
      unitRef="USD">7500</us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000448"
      unitRef="USD">384765</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedSalariesCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000450"
      unitRef="USD">228077</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000452"
      unitRef="USD">88688</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000454"
      unitRef="USD">316765</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2025-01-01to2025-03-31" id="Fact000456">&lt;p id="xdx_80F_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zaM1s83nJyxj" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 7 &#x2013; &lt;span id="xdx_820_zboJB0uZWF0j"&gt;ACCRUED EXPENSES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accrued expenses is comprised of (i) $&lt;span id="xdx_90B_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_c20250331_zmzymTPaaSdh" title="Owed to related parties"&gt;384,765&lt;/span&gt; owed to related parties, (ii)
$&lt;span id="xdx_90B_eus-gaap--LitigationReserveNoncurrent_iI_c20010401_z3ibiSTrgGz" title="Judgment amount"&gt;205,000&lt;/span&gt; related to a judgment against the Company relating to unpaid consulting services dating back to April of 2001, for which collection
has not been sought in two decades so the Company does not expect it will ever have to pay it, (iii) $&lt;span id="xdx_902_eus-gaap--LossContingencyAccrualAtCarryingValue_iI_c20250331_zINdlbsmxnN9" title="Related old accrual"&gt;1,551,425&lt;/span&gt; related to old accruals
for which the statute of limitations has passed and therefore the Company does not expect it will ever have to repay those amounts, (iv)
$&lt;span id="xdx_90E_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_c20250331_zhpXM9iKfbKh" title="Accruals for recurring operating expenses"&gt;10,128&lt;/span&gt; related to accruals for recurring operating expenses, and (v) $&lt;span id="xdx_909_eus-gaap--LegalFees_c20250101__20250331_z6AUOZmITRnc" title="Reimbursement legal fees"&gt;17,780&lt;/span&gt; related to a judgement requiring the Company to reimburse
litigation fees.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000458"
      unitRef="USD">384765</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="AsOf2001-04-01"
      decimals="0"
      id="Fact000460"
      unitRef="USD">205000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000462"
      unitRef="USD">1551425</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000464"
      unitRef="USD">10128</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:LegalFees
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="Fact000466"
      unitRef="USD">17780</us-gaap:LegalFees>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock contextRef="From2025-01-01to2025-03-31" id="Fact000468">&lt;p id="xdx_807_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zyl1zWWjcEC3" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 8 &#x2013; &lt;span id="xdx_825_zCQlRjpoa6F4"&gt;PREPAID EXPENSES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Prepaid expenses is an annual fee paid to the OTC and being amortized over the
life of the subscription. The balance at March 31, 2025 is $&lt;span id="xdx_90F_eus-gaap--PrepaidExpenseCurrent_iI_c20250331_z4mMyk4T3jze" title="Prepaid balance"&gt;6,563&lt;/span&gt;. The balance at December 31, 2024 is $&lt;span id="xdx_902_eus-gaap--PrepaidExpenseCurrent_iI_c20241231_z5PmnFwjFzmb" title="Prepaid balance"&gt;8,750&lt;/span&gt;.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 4pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000470"
      unitRef="USD">6563</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000472"
      unitRef="USD">8750</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:MarketableSecuritiesTextBlock contextRef="From2025-01-01to2025-03-31" id="Fact000474">&lt;p id="xdx_80B_eus-gaap--MarketableSecuritiesTextBlock_zu1RAy47haI2" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 9 &#x2013; &lt;span id="xdx_823_zEqo5xWWPXQ9"&gt;SALE OF MARKETABLE SECURITIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;When Gemaxel Inc. spun off Worlds Online Inc. in January 2011, the Company retained
&lt;span id="xdx_907_ecustom--RetainedShares_iI_c20110101_zu2sd3l1vyV3" title="Number of reatined shares from spin off"&gt;5,936,115&lt;/span&gt; shares of common stock in Worlds Online Inc. (now named MariMed Inc.). Those shares were retained on the books of the Company
with a book value of $&lt;span id="xdx_900_ecustom--RetainedSharesOwnValue_iI_c20250331_zNfjryZjuha1" title="Book value for retained shares"&gt;0&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;During
the three months ended March 31, 2025, there were &lt;span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_do_c20250101__20250331_zeUv9hSeoi0h" title="Shares sold"&gt;no&lt;/span&gt; sales of stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;During the three months ended March 31, 2024, there were &lt;span id="xdx_90D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_do_c20240101__20240331_z1B6TUwLzznk" title="Shares sold"&gt;no&lt;/span&gt; sales of stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As of March 31, 2025, the Company still owns approximately &lt;span id="xdx_905_ecustom--RetainedSharesOwn_iI_c20250331_zS94Pp99hcib" title="Shares owned by MariMed"&gt;350,000&lt;/span&gt; shares of
MariMed Inc. common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:MarketableSecuritiesTextBlock>
    <WDDD:RetainedShares
      contextRef="AsOf2011-01-01"
      decimals="INF"
      id="Fact000476"
      unitRef="Shares">5936115</WDDD:RetainedShares>
    <WDDD:RetainedSharesOwnValue
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="Fact000478"
      unitRef="Shares">0</WDDD:RetainedSharesOwnValue>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2025-01-01to2025-03-31"
      decimals="INF"
      id="Fact000480"
      unitRef="Shares">0</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-01-012024-03-31"
      decimals="INF"
      id="Fact000482"
      unitRef="Shares">0</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <WDDD:RetainedSharesOwn
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="Fact000484"
      unitRef="Shares">350000</WDDD:RetainedSharesOwn>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2025-01-01to2025-03-31" id="Fact000486">&lt;p id="xdx_80E_eus-gaap--SubsequentEventsTextBlock_zEl3NfbbTPW2" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 10 &#x2013; &lt;span id="xdx_82C_zmGqfUd9Ocpi"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In November of 2025 the CEO and Chairman of the Board, Thom Kidrin passed away.
Director Leonard Toboroff was named acting CEO and Chairman of the Board of the Company. The Company changed its name to Gemaxel Inc.
in the 2&lt;sup&gt;nd&lt;/sup&gt; quarter of 2026. The Company evaluates events that have occurred after the balance sheet date but before the financial
statements are issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that
would have required adjustment or disclosure in the financial statements.&#160;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
</xbrl>
